Autumn Wood
Physician Assistant · Gainesville, FLNPI 1881837144
Payments from drug & device makers
Across 167 payments — averaging $22.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1000
- AstraZeneca$392
- Medtronic$297
- AbbVie$292
- Pfizer$212
- Otsuka America Pharmaceutical, Inc.$202
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,815100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 75 | $1,000 |
| AstraZeneca | 5 | $392 |
| Medtronic | 3 | $297 |
| AbbVie | 9 | $292 |
| Pfizer | 9 | $212 |
| Otsuka America Pharmaceutical, Inc. | 5 | $202 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $179 |
| Lilly USA, LLC | 6 | $167 |
| Axsome Therapeutics, Inc. | 2 | $137 |
| Bayer | 6 | $129 |
| Dexcom, Inc. | 2 | $105 |
| GSK | 5 | $98 |
| Grifols USA, LLC | 4 | $84 |
| Johnson & Johnson(2 entities) | 5 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $64 |
| Abbott | 3 | $57 |
| Astellas Pharma US Inc | 2 | $44 |
| Lundbeck LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Biogen | 1 | $21 |
| Boston Scientific | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Radius Health, Inc. | 1 | $17 |
| Valinor Pharma, LLC | 1 | $17 |
| Merck | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Amgen | 1 | $15 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$139
- REXULTI$125
- QULIPTA$123
- UBRELVY$123
- KYPHON EXPRESS II KYPHOPAK TRAY$119
- FARXIGA$119
- AIRSUPRA$119
- Auvelity$113
- CAPLYTA$113
How this compares
$3,815 in reported general payments places this provider in the 85th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 126 | $152,436 |
| JardianceEmpagliflozin | 124 | $149,193 |
| FarxigaDapagliflozin Propanediol | 88 | $87,455 |
| RexultiBrexpiprazole | 46 | $84,063 |
| MounjaroTirzepatide | 66 | $75,806 |
| RybelsusSemaglutide | 41 | $73,431 |
| EliquisApixaban | 63 | $62,386 |
| ProliaDenosumab | 28 | $49,147 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 45 | $38,354 |
| KerendiaFinerenone | 47 | $38,122 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $36,977 |
| XareltoRivaroxaban | 38 | $29,518 |
| MyrbetriqMirabegron | 30 | $24,050 |
| JanuviaSitagliptin Phosphate | 11 | $18,470 |
| UbrelvyUbrogepant | 13 | $17,934 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,000 | $225,867167 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Spiriva Respimat | $16 | $166,692152 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere | $392 | $142,684164 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $202 | $84,06346 claims |
| Lilly USA, LLCMounjaro | $167 | $75,80666 claims |
| PfizerEliquis | $212 | $62,38663 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $98 | $58,41273 claims |
| AmgenProlia | $15 | $49,14728 claims |
| BayerKerendia | $129 | $38,12247 claims |
| AbbVieUbrelvy, Linzess | $292 | $32,85141 claims |
| Johnson & JohnsonXarelto | $81 | $29,51838 claims |
| Astellas Pharma US IncMyrbetriq | $44 | $24,05030 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Gainesville
- Ashley MillerGainesville$328K
- Mary Kate VellisGainesville$79K
- Kelsey KimballGainesville$41K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.